Designed fluorescent probes reveal interactions between amyloid-β(1-40) peptides and GM1 gangliosides in micelles and lipid vesicles

Biophysical Journal

Volumn 99, Issue 5, 2010, Pages 1510-1519

  Mikhalyov, I ^a,b   Olofsson, A ^a   Grobner G ^a   Johansson, L B A ^a  

^a UMEÅ UNIVERSITY   (Sweden)

^b SHEMYAKIN OVCHINNIKOV INSTITUTE OF BIOORGANIC CHEMISTRY   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77956555184     PISSN: 00063495     EISSN: 15420086     Source Type: Journal    
DOI: 10.1016/j.bpj.2010.06.043     Document Type: Article

References (55)

1. Selkoe, D. J. 2004. Cell biology of protein misfolding: the examples of Alzheimer's and Parkinson's diseases. Nat. Cell Biol. 6:1054-1061.
2. Glabe, C. G. 2006. Common mechanisms of amyloid oligomer pathogenesis in degenerative disease. Neurobiol. Aging. 27:570-575.
3. Walsh, D. M., B. P. Tseng., D. J. Selkoe. 2000. The oligomerization of amyloid β-protein begins intracellularly in cells derived from human brain. Biochemistry. 39:10831-10839.
4. Masters, C. L., G. Simms., K. Beyreuther. 1985. Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc. Natl. Acad. Sci. USA. 82:4245-4249.
5. Haass, C., and D. J. Selkoe. 1993. Cellular processing of β-amyloid precursor protein and the genesis of amyloid β-peptide. Cell Biochem. Biophys. 75:1039-1042.
6. Scheuermann, S., B. Hambsch., G. Multhaup. 2001. Homodimerization of amyloid precursor protein and its implication in the amyloidogenic pathway of Alzheimer's disease. J. Biol. Chem. 276:33923-33929.
7. Haass, C., and D. J. Selkoe. 2007. Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide. Nat. Rev. Mol. Cell Biol. 8:101-112.
8. Bucciantini, M., E. Giannoni., M. Stefani. 2002. Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. Nature. 416:507-511.
9. Bokvist, M., F. Lindström., G. Gröbner. 2004. Two types of Alzheimer's β-amyloid (1-40) peptide membrane interactions: aggregation preventing transmembrane anchoring versus accelerated surface fibril formation. J. Mol. Biol. 335:1039-1049.
10. Aisenbrey, C., B. Bechinger, and G. Gröbner. 2008. Macromolecular crowding at membrane interfaces: adsorption and alignment of membrane peptides. J. Mol. Biol. 375:376-385.
11. Chi, E. Y., S. L. Frey, and K. Y. Lee. 2007. Ganglioside G (M1)-mediated amyloid-β fibrillogenesis and membrane disruption. Biochemistry. 46:1913-1924.
12. Kakio, A., S.-I. Nishimoto., K. Matsuzaki. 2002. Interactions of amyloid β-protein with various gangliosides in raft-like membranes: importance of GM1 ganglioside-bound form as an endogenous seed for Alzheimer amyloid. Biochemistry. 41:7385-7390.
13. Matsuzaki, K. 2007. Physicochemical interactionsof amyloid β-peptide with lipid bilayers. Biochim. Biophys. Acta. 1768:1935-1942.
14. McLaurin, J., and A. Chakrabartty. 1996. Membrane disruption by Alzheimer β-amyloid peptides mediated through specific binding to either phospholipids or gangliosides. Implications for neurotoxicity. J. Biol. Chem. 271:26482-26489.
15. Murphy, R. M. 2007. Kinetics of amyloid formation and membrane interaction with amyloidogenic proteins. Biochim. Biophys. Acta. 1768:1923-1934.
16. Terzi, E., G. Hölzemann, and J. Seelig. 1997. Interaction of Alzheimer β-amyloid peptide (1-40) with lipid membranes. Biochemistry. 36:14845-14852.
17. Yeow, E. K. L., and A. H. A. Clayton. 2007. Enumeration of oligomerization states of membrane proteins in living cells by homo-FRET spectroscopy and microscopy: theory and application. Biophys. J. 92:3098-3104.
18. Hartmann, T., J. Kuchenbecker, and M. O. W. Grimm. 2007. Alzheimer's disease: the lipid connection. J. Neurochem. 103 (Suppl 1):159-170.
19. Simons, M., P. Keller., K. Simons. 1998. Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons. Proc. Natl. Acad. Sci. USA. 95:6460-6464.
20. Sawamura, N., M. Morishima-Kawashima., Y. Ihara. 2000. Mutant presenilin 2 transgenic mice. A large increase in the levels of Aβ 42 is presumably associated with the low density membrane domain that contains decreased levels of glycerophospholipids and sphingomyelin. J. Biol. Chem. 275:27901-27908.
21. Kracun, I., S. Kalanj., C. Cosovic. 1992. Cortical distribution of gangliosides in Alzheimer's disease. Neurochem. Int. 20:433-438.
22. Kracun, I., S. Kalanj., J. Talan-Hranilovic. 1990. Brain gangliosides in Alzheimer's disease. J. Hirnforsch. 31:789-793.
23. Nagai, Y. 1995. Functional roles of gangliosides in bio-signaling. Behav. Brain Res. 66:99-104.
24. Yanagisawa, K. 2007. Role of gangliosides in Alzheimer's disease. Biochim. Biophys. Acta. 1768:1943-1951.
25. Choo-Smith, L. P., W. Garzon-Rodriguez., W. K. Surewicz. 1997. Acceleration of amyloid fibril formation by specific binding of Aβ-(1-40) peptide to ganglioside-containing membrane vesicles. J. Biol. Chem. 272:22987-22990.
26. Choo-Smith, L. P., and W. K. Surewicz. 1997. The interaction between Alzheimer amyloid β (1-40) peptide and ganglioside GM1-containing membranes. FEBS Lett. 402:95-98.
27. Kakio, A., S. I. Nishimoto., K. Matsuzaki. 2001. Cholesterol-dependent formation of GM1 ganglioside-bound amyloid β-protein, anendogenous seed for Alzheimer amyloid. J. Biol. Chem. 276:24985-24990.
28. Matsuzaki, K., and C. Horikiri. 1999. Interactions of amyloid β-peptide (1-40) with ganglioside-containing membranes. Biochemistry. 38:4137-4142.
29. Okada, T., M. Wakabayashi., K. Matsuzaki. 2007. Formation of toxic fibrils of Alzheimer's amyloid β-protein-(1-40) by monosialoganglioside GM1, a neuronal membrane component. J. Mol. Biol. 371:481-489.
30. Wakabayashi, M., and K. Matsuzaki. 2007. Formation of amyloids by Aβ-(1-42) on NGF-differentiated PC12 cells: roles of gangliosides and cholesterol. J. Mol. Biol. 371:924-933.
31. Miyashita, N., J. E. Straub, and D. Thirumalai. 2009. Structures of β-amyloid peptide 1-40, 1-42, and 1-55-the 672-726 fragment of APP-in a membrane environment with implications for interactions with γ-secretase. J. Am. Chem. Soc. 131:17843-17852.
32. Yamamoto, N., K. Hasegawa., K. Yanagisawa. 2004. Environmentand mutation-dependent aggregation behavior of Alzheimer amyloid β-protein. J. Neurochem. 90:62-69.
33. Mikaelsson, T., R. Sachl, and L. B.-Å. Johansson. 2007. Electronic energy transport and fluorescence spectroscopy for structural insights into proteins, regular protein aggregates and lipid systems. In Reviews in Fluorescence 2007. C. D. Geddes, editor. Springer, New York. 53-86.
34. Marushchak, D., N. Gretskaya., L. B. Johansson. 2007. Self-aggregation-an intrinsic property of G (M1) in lipid bilayers. Mol. Membr. Biol. 24:102-112.
35. Bogen, S.-T., G. de Korte-Kool., L. B.-Å. Johansson. 1999. Aggregation of an α-helical transmembrane peptide in lipid phases, studied by time resolved fluorescence spectroscopy. J. Phys. Chem. B. 103:8344-8352.
36. Durell, S. R., H. R. Guy., H. B. Pollard. 1994. Theoretical models of the ion channel structure of amyloid β-protein. Biophys. J. 67:2137-2145.
37. Xu, Y., J. Shen., H. Jiang. 2005. Conformational transition of amyloid β-peptide. Proc. Natl. Acad. Sci. USA. 102:5403-5407.
38. Stine, Jr., W. B., K. N. Dahlgren., M. J. LaDu. 2003. In vitro characterization of conditions for amyloid-β peptide oligomerization and fibrillogenesis. J. Biol. Chem. 278:11612-11622.
39. Fa, M., F. Bergström., T. Ny. 2000. The structure of a serpinprotease complex revealed by intramolecular distance measurements using donor-donor energy migration and mapping of interaction sites. Structure. 8:397-405.
40. Sachl, R., I. Mikhalyov., L. B. Johansson. 2009. A comparative study on ganglioside micelles using electronic energy transfer, fluorescence correlation spectroscopy and light scattering techniques. Phys. Chem. Chem. Phys. 11:4335-4343.
41. Svennerholm, L. 1972. In Methods in Carbohydrate Chemistry., R. L. Whistler and J. N. BeMiller, editors. Academic Press, New York. 464-474.
42. Reference deleted in proof.
43. Heyn, M. P. 1979. Determination of lipid order parameters and rotational correlation times from fluorescence depolarization experiments. FEBS Lett. 108:359-364.
44. Lakowicz, J. R. 2006. Principles of Fluorescence Spectroscopy, 3rd ed. Springer, Singapore.
45. Bergström, F., I. Mikhalyov., L. B. Johansson. 2002. Dimers of dipyrrometheneboron difluoride (BODIPY) with light spectroscopic applications in chemistry and biology. J. Am. Chem. Soc. 124:196-204.
46. Kalinin, S., and L. B.-Å. Johansson. 2004. Utility and considerations of donor-donor energy migration as a fluorescence method for exploring protein structure-function. J. Fluoresc. 14:681-691.
47. Karolin, J., L. B.-Å. Johansson., T. Ny. 1994. Fluorescence and absorption spectroscopic properties of dipyrrometheneboron difluoride (BODIPY) derivatives in liquids, lipid membranes, and proteins. J. Am. Chem. Soc. 116:7801-7806.
48. Kalinin, S. V., J. G. Molotkovsky, and L. B.-Å. Johansson. 2002. Partial donor-donor energy migration (PDDEM) as a fluorescence spectroscopic tool for measuring distances in biomacromolecules. Spectrochim. Acta A Mol. Biomol. Spectrosc. 58:1087-1097.
49. Mobley, D. L., D. L. Cox., M. L. Longo. 2004. Modeling amyloid β-peptide insertion into lipid bilayers. Biophys. J. 86:3585-3597.
50. Shnyrova, A. V., J. Ayllon., V. A. Frolov. 2007. Vesicle formation by self-assembly of membrane-bound matrix proteins into a fluidlike budding domain. J. Cell Biol. 179:627-633.
51. Yanagisawa, K., A. Odaka., Y. Ihara. 1995. GM1 ganglioside-bound amyloid β-protein (A β): a possible form of preamyloid in Alzheimer's disease. Nat. Med. 1:1062-1066.
52. Jarvet, J., J. Danielsson., A. Gräslund. 2007. Postioning of the Alzheimer Aβ (1-40) peptide in micelles using NMR and paramagnetic probes. J. Biomol. NMR. 39:63-72.
53. Utsumi, M., Y. Yamaguchi., K. Kato. 2009. Up-and-down topological mode of amyloid β-peptide lying on hydrophilic/hydrophobic interface of ganglioside clusters. Glycoconj. J. 26:999-1006.
54. Yagi-Utsumi, M., T. Kameda., K. Kato. 2010. NMR characterization of the interactions between lyso-GM1 aqueous micelles and amyloid β. FEBS Lett. 584:831-836.
55. Coles, M., W. Bicknell., D. J. Craik. 1998. Solution structure of amyloid β-peptide (1-40) in a water-micelle environment. Is the membrane-spanning domain where we think it is? Biochemistry. 37:11064-11077.